THE EFFECT OF SMOKING ON THE COURSE OF THE DISEASE AND LIPID METABOLISM IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA

Introduction. Community-acquired pneumonia (CAP) is a disease associated with a high risk of complications and mortality, which depends on various risk factors. Smoking is one such factor that contributes to an unfavorable prognosis in various conditions. Objectives. This study aimed to assess the i...

Full description

Saved in:
Bibliographic Details
Main Authors: Olena Sorokopud, Olesia Besh, Oksana Romanyshyn, Dmytro Reshot’ko
Format: Article
Language:English
Published: Edeme Resort Medical & Spa 2025-06-01
Series:Anti-Aging Eastern Europe
Subjects:
Online Access:https://antiagingeeu.com/index.php/journal/article/view/134
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849425742599815168
author Olena Sorokopud
Olesia Besh
Oksana Romanyshyn
Dmytro Reshot’ko
author_facet Olena Sorokopud
Olesia Besh
Oksana Romanyshyn
Dmytro Reshot’ko
author_sort Olena Sorokopud
collection DOAJ
description Introduction. Community-acquired pneumonia (CAP) is a disease associated with a high risk of complications and mortality, which depends on various risk factors. Smoking is one such factor that contributes to an unfavorable prognosis in various conditions. Objectives. This study aimed to assess the impact of smoking status on the course of CAP and to explore the relationship between smoking, pneumonia severity, and lipid metabolism. A total of 255 patients with CAP were included and divided into two groups: those with moderately severe pneumonia (119 patients) and those with severe pneumonia (136 patients). Among the examined patients, men predominated, and the vast majority were young. The most common complications included pleurisy, myocarditis, and renal dysfunction. Results. The incidence of complications and severe clinical course of CAP was similar in smokers and non-smokers. However, decreased body mass index (BMI) was slightly more common in smokers. Notably, low body mass was twice as frequent among smokers with severe pneumonia compared to non-smokers with severe disease. Systolic and diastolic blood pressure values were significantly lower in smokers. The number of peripheral blood leukocytes was significantly higher in smokers. C-reactive protein (CRP) levels were elevated in both groups. While the average fibrinogen levels did not differ significantly between groups, hyperfibrinogenemia (>10 g/L) was more common in smokers with severe pneumonia. Cholesterol levels were significantly lower in smokers, especially in those with severe CAP. Conclusions. The observed association between smoking and reduced cholesterol levels highlights a potential impact of smoking on lipid metabolism. Smoking cessation may improve lipid profiles and reduce the risk of severe complications in pneumonia and other diseases.
format Article
id doaj-art-92ab5b5d4cd24b818c32a298f30e1759
institution Kabale University
issn 2786-6521
2786-6157
language English
publishDate 2025-06-01
publisher Edeme Resort Medical & Spa
record_format Article
series Anti-Aging Eastern Europe
spelling doaj-art-92ab5b5d4cd24b818c32a298f30e17592025-08-20T03:29:39ZengEdeme Resort Medical & SpaAnti-Aging Eastern Europe2786-65212786-61572025-06-014212112710.56543/aaeeu.2025.4.2.07134THE EFFECT OF SMOKING ON THE COURSE OF THE DISEASE AND LIPID METABOLISM IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIAOlena Sorokopud0Olesia Besh1Oksana Romanyshyn2Dmytro Reshot’ko3Danylo Halytsky Lviv National Medical University, Department of Internal Medicine No. 2, Lviv, Ukraine; “Longevity” Medical Centre, Lviv, Ukraine; Edem Medical Center, Department of Research and Innovation, Strilky, Ukraine Danylo Halytsky Lviv National Medical University, Department of Internal Medicine No. 2, Lviv, Ukraine; University Hospital, Danylo Halytsky Lviv National Medical University, Division of Internal Diseases, Lviv, Ukraine; “Longevity” Medical Centre, Lviv, Ukraine University Hospital, Danylo Halytsky Lviv National Medical University, Division of Internal Diseases, Lviv, Ukraine Bogomolets National Medical University, Department of Internal Medicine No. 1, Kyiv, Ukraine Introduction. Community-acquired pneumonia (CAP) is a disease associated with a high risk of complications and mortality, which depends on various risk factors. Smoking is one such factor that contributes to an unfavorable prognosis in various conditions. Objectives. This study aimed to assess the impact of smoking status on the course of CAP and to explore the relationship between smoking, pneumonia severity, and lipid metabolism. A total of 255 patients with CAP were included and divided into two groups: those with moderately severe pneumonia (119 patients) and those with severe pneumonia (136 patients). Among the examined patients, men predominated, and the vast majority were young. The most common complications included pleurisy, myocarditis, and renal dysfunction. Results. The incidence of complications and severe clinical course of CAP was similar in smokers and non-smokers. However, decreased body mass index (BMI) was slightly more common in smokers. Notably, low body mass was twice as frequent among smokers with severe pneumonia compared to non-smokers with severe disease. Systolic and diastolic blood pressure values were significantly lower in smokers. The number of peripheral blood leukocytes was significantly higher in smokers. C-reactive protein (CRP) levels were elevated in both groups. While the average fibrinogen levels did not differ significantly between groups, hyperfibrinogenemia (>10 g/L) was more common in smokers with severe pneumonia. Cholesterol levels were significantly lower in smokers, especially in those with severe CAP. Conclusions. The observed association between smoking and reduced cholesterol levels highlights a potential impact of smoking on lipid metabolism. Smoking cessation may improve lipid profiles and reduce the risk of severe complications in pneumonia and other diseases.https://antiagingeeu.com/index.php/journal/article/view/134community-acquired pneumoniasmokinglipidslipid metabolismcomplications
spellingShingle Olena Sorokopud
Olesia Besh
Oksana Romanyshyn
Dmytro Reshot’ko
THE EFFECT OF SMOKING ON THE COURSE OF THE DISEASE AND LIPID METABOLISM IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA
Anti-Aging Eastern Europe
community-acquired pneumonia
smoking
lipids
lipid metabolism
complications
title THE EFFECT OF SMOKING ON THE COURSE OF THE DISEASE AND LIPID METABOLISM IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA
title_full THE EFFECT OF SMOKING ON THE COURSE OF THE DISEASE AND LIPID METABOLISM IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA
title_fullStr THE EFFECT OF SMOKING ON THE COURSE OF THE DISEASE AND LIPID METABOLISM IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA
title_full_unstemmed THE EFFECT OF SMOKING ON THE COURSE OF THE DISEASE AND LIPID METABOLISM IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA
title_short THE EFFECT OF SMOKING ON THE COURSE OF THE DISEASE AND LIPID METABOLISM IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA
title_sort effect of smoking on the course of the disease and lipid metabolism in patients with community acquired pneumonia
topic community-acquired pneumonia
smoking
lipids
lipid metabolism
complications
url https://antiagingeeu.com/index.php/journal/article/view/134
work_keys_str_mv AT olenasorokopud theeffectofsmokingonthecourseofthediseaseandlipidmetabolisminpatientswithcommunityacquiredpneumonia
AT olesiabesh theeffectofsmokingonthecourseofthediseaseandlipidmetabolisminpatientswithcommunityacquiredpneumonia
AT oksanaromanyshyn theeffectofsmokingonthecourseofthediseaseandlipidmetabolisminpatientswithcommunityacquiredpneumonia
AT dmytroreshotko theeffectofsmokingonthecourseofthediseaseandlipidmetabolisminpatientswithcommunityacquiredpneumonia
AT olenasorokopud effectofsmokingonthecourseofthediseaseandlipidmetabolisminpatientswithcommunityacquiredpneumonia
AT olesiabesh effectofsmokingonthecourseofthediseaseandlipidmetabolisminpatientswithcommunityacquiredpneumonia
AT oksanaromanyshyn effectofsmokingonthecourseofthediseaseandlipidmetabolisminpatientswithcommunityacquiredpneumonia
AT dmytroreshotko effectofsmokingonthecourseofthediseaseandlipidmetabolisminpatientswithcommunityacquiredpneumonia